| Name | Title | Contact Details |
|---|---|---|
Mark Quick |
Chief Financial Officer | Profile |
David Sharp |
Vice President of Global Marketing | Profile |
Urologix, Inc., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). Urologix`s Cooled ThermoTherapy™ produces targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva® RF Therapy System delivers radio frequency energy directly into the prostate, destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH symptoms. Both therapies provide safe, effective and lasting relief of the symptoms and obstruction due to BPH. Prostiva is a registered trademark of Medtronic, Inc., used under license. All other trademarks are the property of Urologix.
Vitale Group is a Lutherville Timonium, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Mirabilis Medica is a Bothell, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mexpo International is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DMG America is a Englewood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.